DE69406115D1 - Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome - Google Patents

Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome

Info

Publication number
DE69406115D1
DE69406115D1 DE69406115T DE69406115T DE69406115D1 DE 69406115 D1 DE69406115 D1 DE 69406115D1 DE 69406115 T DE69406115 T DE 69406115T DE 69406115 T DE69406115 T DE 69406115T DE 69406115 D1 DE69406115 D1 DE 69406115D1
Authority
DE
Germany
Prior art keywords
serum
respiratory distress
distress syndrome
adult respiratory
antioxyding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69406115T
Other languages
English (en)
Other versions
DE69406115T2 (de
Inventor
John E Repine
Joanathan A Leff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEBB WARING INST FOR BIOMEDICA
University of Colorado Boulder
Original Assignee
WEBB WARING INST FOR BIOMEDICA
University of Colorado Boulder
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEBB WARING INST FOR BIOMEDICA, University of Colorado Boulder filed Critical WEBB WARING INST FOR BIOMEDICA
Publication of DE69406115D1 publication Critical patent/DE69406115D1/de
Application granted granted Critical
Publication of DE69406115T2 publication Critical patent/DE69406115T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/30—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving catalase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96447—Factor VII (3.4.21.21)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69406115T 1993-03-19 1994-03-18 Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome Expired - Fee Related DE69406115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/034,935 US5389522A (en) 1993-03-19 1993-03-19 Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients
PCT/US1994/002925 WO1994022016A1 (en) 1993-03-19 1994-03-18 Serum antioxidants as predictors of adult respiratory distress syndrome

Publications (2)

Publication Number Publication Date
DE69406115D1 true DE69406115D1 (de) 1997-11-13
DE69406115T2 DE69406115T2 (de) 1998-04-30

Family

ID=21879562

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69406115T Expired - Fee Related DE69406115T2 (de) 1993-03-19 1994-03-18 Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome

Country Status (9)

Country Link
US (2) US5389522A (de)
EP (2) EP0689674B1 (de)
JP (1) JPH08511864A (de)
AT (1) ATE159102T1 (de)
AU (1) AU690106B2 (de)
CA (1) CA2158579C (de)
DE (1) DE69406115T2 (de)
NO (1) NO953689D0 (de)
WO (1) WO1994022016A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
US5679532A (en) * 1995-12-13 1997-10-21 University Technology Corporation Serum ferritin as a predictor of the acute respiratory distress syndrome
MXPA05005073A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
EP1562046A1 (de) * 2004-02-03 2005-08-10 B.R.A.H.M.S Aktiengesellschaft Diagnose von Sepsis durch selektive Bestimmung der Konzentration der Cu/Zn Superoxiddismutase (Cu/Zn SOD) in Patientenproben
WO2007143066A2 (en) * 2006-05-31 2007-12-13 Health Research Inc. Method for predicting susceptibility to radiation pneumonitis
ES2549460T3 (es) * 2009-11-03 2015-10-28 F. Hoffmann-La Roche Ag NT-pro ANP y sFlt-1 para la diferenciación entre los eventos isquémicos y circulatorios
SE535502C2 (sv) * 2010-09-14 2012-08-28 Calmark Sweden Ab System och metod för att analysera risk eller förekomst av organsvikt
TW202308659A (zh) * 2021-05-06 2023-03-01 愛爾蘭商爵士製藥愛爾蘭有限責任公司 用於急性呼吸窘迫症候群之治療及預防的去纖維蛋白多核苷酸

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3926732A (en) * 1973-02-16 1975-12-16 Alfa Laval Ab Method for assaying catalase in milk and other liquids
US5147783A (en) * 1988-05-27 1992-09-15 Ube Industries, Ltd. Methods to screen for ovarian cancer and myocardial infarction
US5389522A (en) * 1993-03-19 1995-02-14 Repine; John E. Serum antioxidants as predictors of the adult respiratory distress syndrome in septic patients

Also Published As

Publication number Publication date
CA2158579C (en) 1999-01-26
EP0689674B1 (de) 1997-10-08
AU690106B2 (en) 1998-04-23
EP0757105A3 (de) 1998-01-28
DE69406115T2 (de) 1998-04-30
ATE159102T1 (de) 1997-10-15
US5389522A (en) 1995-02-14
EP0757105A2 (de) 1997-02-05
AU6448194A (en) 1994-10-11
CA2158579A1 (en) 1994-09-29
NO953689D0 (no) 1995-09-19
JPH08511864A (ja) 1996-12-10
EP0689674A1 (de) 1996-01-03
US5639629A (en) 1997-06-17
WO1994022016A1 (en) 1994-09-29

Similar Documents

Publication Publication Date Title
DE69921668D1 (de) Nachweis und bestimmung von stufen der coronaren arterienerkrankung
DE3880372D1 (de) Verfahren und geraet zur bestimmung des alkoholspiegels von personen.
DE3853671D1 (de) Reagens und Verfahren zur Messung von Leukozyten und Hämoglobin im Blut.
DE3382767D1 (de) Ein Verfahren zur Herstellung eines Antikörpers, der zur Bestimmung der Anwesenheit eines menschlichen Oncogens befähigt ist.
DE69018910D1 (de) Verfahren zur Bestimmung des endogenen Thrombinpotentials von Plasma und Blut und Reagenziensatz zur Verwendung in besagtem Verfahren.
DE69536018D1 (de) Vorrichtung zur Verabreichung von Medikamenten mit einem Mikroprozessor und einem Kennzeichenmonitor
DE3767123D1 (de) Verfahren zur bestimmung des haematokrit aus vollblut sowie vorrichtung zur durchfuehrung des verfahrens.
DE69406115D1 (de) Serum antioxydationsmittel zur voraussage von adult respiratory distress syndrome
DE3765310D1 (de) Vorrichtung zur bestimmung von gaspartialdruecken im blut.
AT362080B (de) Verfahren und reagens zur bestimmung der gerinnungsverhindernden aktivitaet im plasma
ATE127853T1 (de) Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
ATE198772T1 (de) Verfahren zum spezifischen nachweis eines aktivierten gerinnungsfaktors v mit einer erhöhten stabilität gegenüber aktiviertem protein c
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
ATE12699T1 (de) Reagens zur praezipitation apo-b-haltiger lipoproteine, verfahren zu dessen herstellung und dessen verwendung bei der bestimmung von hdl- cholesterin.
ATE148233T1 (de) Verfahren zur bestimmung von thrombose verursachenden lupus-anticoagulant-antikörpern
DE59108478D1 (de) Funktioneller Test zur Bestimmung der Protein S-Aktivität
ATE56097T1 (de) Mittel zur bestimmung von peroxidase-aktivitaet, verfahren zur herstellung und seine verwendung.
DE3882770D1 (de) Verfahren und reagens zur bestimmung von dehydrogenase oder ihrem substrat.
DE59611194D1 (de) Verfahren und mittel zur bestimmung von jodid
ATE211825T1 (de) Verfahren zur feststellung einer allergie
ATE208505T1 (de) Verfahren und reagenz zur überwachung des blutspiegels von antiplättchen-verbindungen
ATA81987A (de) Verfahren zur bestimmung des aktuellen pegels von cyclosporin-a bzw. des diesem verwandter immunsuppressiva sowie jenes deren biologisch aktiver metaboliten im blut
DE69628659D1 (de) Verfahren zur bestimmung von blutgerinnungsfaktoren viii und ix
DE59308274D1 (de) Verfahren und Standardlösung zur Bestimmung von Thyroxin (T4) oder Trijodthyronin (T3)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee